Cancer Research UK
Support Cancer Research UK Today
WHY CANCER RESEARCH UK NEED YOUR SUPPORT
Cancer Research UK are the world's leading independent cancer charity dedicated to saving lives through research, influence, and information.
HOW TO SUPPORT CANCER RESEARCH UK
Join Cancer Research UK to join over a thousand others who are playing their part in supporting vital cancer research. To run the adidas Manchester Marathon as a charity runner, you’ll need to pay a registration fee of £20 and set a fundraising target of £750.
If you have already secured a place, you can still use it to raise funds for Cancer Research UK
PARTICIPATING FOR CANCER RESEARCH UK
When you participate for Cancer Research UK, you'll receive:
- A personalised Cancer Research UK running t-shirt or vest
- Training tips and plans to help you prepare
- Fundraising support to help you smash your target
- Support on the day at cheer points along the route
- A post-event reception to celebrate
RESEARCH HAPPENING RIGHT NOW IN MANCHESTER
In Manchester, Professor Caroline Dive and Professor Phil Crosbie are developing blood tests to detect early-stage lung cancer. They’re investigating whether these tests could improve screening, by comparing and combining them with other methods.
This research could lead to more lung cancers being detected at an early stage, increasing the likelihood that people’s treatment is successful.
COMMUNITY WORK HAPPENING RIGHT NOW IN MANCHESTER
Talk Cancer is a cancer awareness training programme that equips people with the knowledge, skills and confidence to have effective conversations about cancer and health.
Cancer Research UK delivered our largest number of workshops in the NW region at 33 workshops.
Cancer Research UK trained 382 people across 20 online workshops and 13 face-to-face workshops.
Cancer Research UK delivered 18 workshops across Greater Manchester as part of our partnership with Greater Manchester Cancer Alliance, training staff and community leaders that work and interact with groups who experience inequalities, particularly around incidence and early diagnosis of cancer.


